230 related articles for article (PubMed ID: 24916867)
1. Frequency and antibiotic susceptibility patterns of urinary pathogens in male outpatients in Argentina.
Villar HE; Jugo MB; Macan A; Visser M; Hidalgo M; Maccallini GC
J Infect Dev Ctries; 2014 Jun; 8(6):699-704. PubMed ID: 24916867
[TBL] [Abstract][Full Text] [Related]
2. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
5. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
[TBL] [Abstract][Full Text] [Related]
6. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.
Akram M; Shahid M; Khan AU
Ann Clin Microbiol Antimicrob; 2007 Mar; 6():4. PubMed ID: 17378940
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.
Demir T; Buyukguclu T
Int J Infect Dis; 2013 Nov; 17(11):e966-70. PubMed ID: 23742831
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
Taneja N; Rao P; Arora J; Dogra A
Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
[TBL] [Abstract][Full Text] [Related]
9. [Extended-spectrum beta-lactamase production by Enterobacteriaceae isolates from urine cultures of outpatients: results of a 7-year follow-up].
Çelikbilek N; Gözalan A; Özdem B; Kırca F; Açıkgöz ZC
Mikrobiyol Bul; 2015 Apr; 49(2):259-65. PubMed ID: 26167826
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection.
Khan IU; Mirza IA; Ikram A; Afzal A; Ali S; Hussain A; Fayyaz M; Ghafoor T
J Coll Physicians Surg Pak; 2014 Nov; 24(11):840-4. PubMed ID: 25404444
[TBL] [Abstract][Full Text] [Related]
11. An update on the management of urinary tract infections in the era of antimicrobial resistance.
Bader MS; Loeb M; Brooks AA
Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).
Cantón R; Loza E; Aznar J; Calvo J; Cercenado E; Cisterna R; Romo FG; Hontangas JL; Calvo CR; Barrenechea AI; Tubau F; Weber I; Yuste P; Cavanillas R;
Rev Esp Quimioter; 2011 Dec; 24(4):223-32. PubMed ID: 22173194
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.
Yeshitela B; Gebre-Selassie S; Feleke Y
Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407
[TBL] [Abstract][Full Text] [Related]
15. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
Aykut Arca E; Karabiber N
Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
[TBL] [Abstract][Full Text] [Related]
16. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents.
Bader MS; Loeb M; Leto D; Brooks AA
Postgrad Med; 2020 Apr; 132(3):234-250. PubMed ID: 31608743
[TBL] [Abstract][Full Text] [Related]
17. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia.
Kader AA; Angamuthu K
Saudi Med J; 2005 Jun; 26(6):956-9. PubMed ID: 15983682
[TBL] [Abstract][Full Text] [Related]
18. Hospital and community isolates of uropathogens at a tertiary hospital in South Africa.
Habte TM; Dube S; Ismail N; Hoosen AA
S Afr Med J; 2009 Aug; 99(8):584-7. PubMed ID: 19908617
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon.
Araj GF; Jaber FA
J Med Liban; 2012; 60(3):142-7. PubMed ID: 23198454
[TBL] [Abstract][Full Text] [Related]
20. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region.
Hsueh PR; Hoban DJ; Carmeli Y; Chen SY; Desikan S; Alejandria M; Ko WC; Binh TQ
J Infect; 2011 Aug; 63(2):114-23. PubMed ID: 21669223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]